|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.85 CNY | +2.39% |
|
-1.38% | -21.31% |
BCY Pharm Co., Ltd. announced that it will raise CNY 150,000,000 in a round of funding on August 25, 2023. The transaction included participation from returning investors, Guangdong Taienkang Pharmaceutical Co., Ltd for CNY 150,000,000. The company will raise CNY 9,986,250 into registered capital and CNY 140,001,375,000 into capital surplus.
The transaction has been approved by 21st meeting of the 4th board of directors for proposal on capital increase of controlled subsidiary.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.31% | 73Cr | |
| +54.68% | 81TCr | |
| +44.25% | 65TCr | |
| -6.19% | 35TCr | |
| +21.32% | 34TCr | |
| +11.03% | 30TCr | |
| +18.45% | 25TCr | |
| +2.09% | 23TCr | |
| +13.03% | 22TCr | |
| +8.93% | 17TCr |
GUANGDONG TAIENKANG PHARMACEUTICAL CO., LTD. 
